Merck
@Merck
We’re proud to announce the #FDA approvals of two new immunotherapy-based treatment combinations for certain adults with advanced triple negative breast cancer (#TNBC). This milestone, in collaboration with @GileadSciences, is an important step forward in care for patients with
12 15